Rick Kash and Dimitri Panayotopoulos join IRI board of directors

September 13, 2019 by Chain Drug Review Andrew Appel, Dimitri Panayotopoulos, IRI, Jeffrey Ansell, Rick Kash Business, Leading Headlines, Supplier News

CHICAGO — IRI announced that Rick Kash and Dimitri Panayotopoulos will join the company’s board of directors, effective immediately. IRI is a portfolio company of Vestar Capital Partners and New Mountain Capital. “We are very pleased to have Rick and Dimitri — two highly accomplished consumer goods professionals who are well respected in the industry